FROM THE EDITOR
Every CLO has lived through a key partner leaving in the middle of a matter. You get the call and the transition memo, and you take the new firm’s word that the conflicts check is “a formality.” It is disruptive, but it is manageable, because the old firm is still there to hand over the file.
Weil, Gotshal & Manges is a different problem. On November 10, roughly 97% of Weil’s partners voted to wind the firm down. A 95-year-old firm with about 1,200 lawyers and more than $2 billion in revenue will stop practicing. Its lawyers are dispersing to Kirkland, Gibson Dunn, Sidley, Paul Weiss, Cravath, Davis Polk, Skadden, Latham and others, a group at a time. Remaining equity partners will be deemed withdrawn by December 31.
If your company has a live matter at Weil, you have about six weeks to decide where it goes and to make sure it actually gets there. The firm doing the handing over is closing as it goes.
This issue is the checklist I would want if one of my matters were on Weil’s docket. It is also a reminder for the rest of us that the stability of a law firm is now a diligence item.
Sources: Bloomberg Law (Oct. 28 and Nov. 6, 2026); Reuters (Oct. 28–29, Nov. 12, 2026); Law.com/The American Lawyer (Nov. 10, 2026); ABA Journal (Nov. 13, 2026); Vargas Partners; Managing IP. Reported lateral moves are as reported and may change. I have no information about any Weil client’s matters, and nothing here is legal advice.
— John LaRocca
WHAT HAPPENED IN 60 SECONDS
The exodus. Nearly 60 partners left Weil or announced departures in 2026, more than half of them after August. They included:
Corporate/M&A chair Michael Aiello and five M&A partners, to Cravath;
private equity co-heads Doug Warner and Chris Machera, to Paul Weiss;
securities litigation head Caroline Zalka, to Paul Weiss;
litigators Drew Tulumello and Chantale Fiebig, to Davis Polk;
regulatory partners Andrew Dean and Christopher Mulligan, to Skadden.
The failed rescue. Merger talks with Vinson & Elkins and then Willkie Farr went nowhere. On October 25, Ramona Nee, elected to succeed Barry Wolf as executive partner, said she would not take the role.
The decision. On October 28, the management committee recommended an “orderly wind-down,” and on November 10 the partners approved it by about 97%. The process is meant to be solvent and out of court. It is advised by AlixPartners, C Street Advisory Group and Davis Polk, and run by a three-person wind-down committee.
Where the lawyers are going, as reported:
Gibson Dunn: a 120-lawyer private funds group, including co-managing partner Jonathon Soler, starting in January.
Kirkland: about 40 lawyers, including Nee, in January.
Sidley: in talks for about 200 people.
Latham and Skadden: IP lawyers.
The deadline that matters. A November 5 memo told remaining equity partners they will be deemed withdrawn by year-end. Partners who give notice now can leave immediately and keep their right to a later profit distribution. The firm said it “will continue serving clients” during the wind-down.
THE DATE THAT MATTERS IS DECEMBER 31
The headline is the vote. The operational fact is the memo. Once equity partners are deemed withdrawn at year-end, the people who supervise your matter will have left. The firm’s incentive structure has already flipped: a partner who resigns today keeps economic rights, and one who waits gains nothing.
Expect three things between now and January:
Teams will split. A group moving to one firm may not include the associate who knows your file, the paralegal who maintains your docket, or the partner who argued the last motion. Lateral packages are negotiated around books of business and practice groups, not around your matter.
The infrastructure will thin. Docketing, records, litigation support, IT and billing staff are on 90-day pay. The people who can export a document review database or confirm a court deadline may leave before the lawyers do.
Court and deal calendars will not wait. No tribunal pauses because counsel’s firm is dissolving. A response date, an expert deadline, a closing condition or a regulatory filing that falls in December is your problem, not Weil’s.
THE CLIENT CHOOSES
The first principle is simple and is often forgotten in a lateral scramble. The matter belongs to the client, not to the departing lawyer and not to the dissolving firm. The ethics rules and bar guidance on departing lawyers consistently treat the choice of counsel as the client’s. The firm and the lawyer must tell you what is happening, and your files must follow your instructions.
That has a practical consequence. Do not let the transition memo make the decision for you. A letter saying “Partner X is joining Firm Y and your matter will move with her” is a proposal. Before you accept it, answer three questions:
Is the team that knows the matter actually moving together? Get names, not group descriptions.
Can the receiving firm take the matter? Conflicts, protective-order eligibility and, for some matters, court or regulatory approval all come first.
Is this the right moment to re-compete the matter? A forced transition is also a natural point to revisit staffing, rates and fee structure. That is not opportunism; you are signing a new engagement letter either way.
THE TRANSITION LIST: SEVEN WORKSTREAMS
1. Litigation: Substitution and Deadlines
In most courts, counsel cannot simply leave a case. Withdrawal requires leave of court unless substitute counsel appears. Bankruptcy and other court-supervised engagements may require a new retention application.
For each Weil litigation matter, confirm:
who will file the substitution and by when;
that no deadline falls inside the transition window without a named owner;
that the docketing calendar has been exported and reconciled against the court docket itself, not against Weil’s internal system.
2. Protective Orders and Prosecution Bars
This is the life sciences issue. See the box below.
3. Conflicts at the Receiving Firm
The receiving firm will run its own conflicts check on your matter, and the result may surprise you. A firm with a large life sciences practice may represent your competitor, the generic filer in your next Hatch-Waxman case, or the counterparty in your licensing dispute.
Ask for the result in writing before you sign the engagement letter, including:
any ethical screens required for incoming lawyers;
any advance waivers the firm will ask you to give.
Do not give a broad advance waiver to solve a transition problem.
4. Transactions: Opinions, Agents and the Long Tail
For deals, the risk is in the obligations that outlast the closing:
legal opinions Weil delivered or is scheduled to deliver;
escrow-agent, paying-agent or notice-recipient roles naming the firm or a Weil lawyer;
post-closing roles in milestone, CVR or earnout disputes, and indemnity claims where Weil’s lawyers hold the institutional knowledge;
pending regulatory filings (HSR, CFIUS, foreign merger control) where Weil is counsel of record.
Each needs a named replacement and, where a contract or filing designates the firm, a written amendment or notice.
5. Files, Data and Privilege
Your file is more than the document management system. Inventory and transfer:
the DMS file;
email correspondence;
document review databases hosted by e-discovery vendors under Weil’s contracts;
deal data-room access;
expert and consultant work product;
litigation-hold data Weil preserved on your behalf.
Three rules apply:
Transfer privileged material only to counsel of record. Use an agreed method and a chain of custody.
Get vendor-hosted data moved before Weil’s vendor contracts lapse. Otherwise a review platform can go dark mid-matter.
Get written confirmation of what was returned, what was transferred and what was destroyed, signed by someone with authority at the wind-down committee level.
6. Money
Reconcile before year-end:
final invoices;
unbilled work in progress;
unapplied retainers and credits;
any alternative-fee, capped-fee or success-fee arrangement.
Ask how a fixed or contingent fee will be apportioned between Weil and the receiving firm. Do not pay twice for the same transition work.
There is also a question for the partners rather than for you, but it affects you. Who is entitled to profits on “unfinished business”? New York’s highest court (In re Thelen LLP, 2014) and the California Supreme Court (Heller Ehrman LLP v. Davis Wright Tremaine, 2018) both held that pending hourly matters are not partnership property of a dissolved firm. Weil’s partnership agreement and the ten former partners who have reportedly retained counsel over the firm’s assets will sort out the rest. Your concern is narrower: make sure no partner dispute delays your file or your final bill. Have your counsel confirm current law in the relevant jurisdictions before relying on either case.
7. Malpractice Tail and Insurance
Claims arising from work Weil performed may surface after the firm is gone. Ask the wind-down committee to confirm in writing:
the professional liability tail coverage;
its limits;
the notice address for claims.
Record the answer in the matter file. You will not get a second chance to ask.
BOX1: THE PROTECTIVE ORDER PROBLEM
For life sciences CLOs with Hatch-Waxman, BPCIA or other confidential-information litigation at Weil
Patent cases between brand and generic or biosimilar companies run on protective orders that limit the other side’s confidential information to designated outside counsel. Many of those orders:
name or require disclosure of individual attorneys who may see “outside counsel eyes only” material;
impose patent prosecution bars on anyone who sees technical confidential information. Courts evaluate these under In re Deutsche Bank Trust Co. Americas (Fed. Cir. 2010);
tie access to the attorney’s firm, with notice and objection periods before new people may see designated material.
When a Weil team moves, the same lawyers continue under a new firm name. The order may still require new designations, notice to the other side and time for objections. The other side’s information already in Weil’s systems must be handled, returned or destroyed exactly as the order specifies.
The receiving firm’s prosecution practice becomes your problem. If the new firm prosecutes patents in the same technical field for other clients, opposing counsel may object to your lawyers’ access. At minimum, they will use the moment to renegotiate.
Ask now:
Does each of our protective orders require notice or consent before a lawyer’s change of firm takes effect?
Does the receiving firm have a patent prosecution practice in the relevant field, and how will the bar be maintained?
Who at Weil certifies the return or destruction of the other side’s material, and when?
The cost of a missed step here is not a scheduling issue. It is a motion to disqualify your trial team in the year your exclusivity is decided.
BOX 2: THE LETTER TO SEND THIS WEEK
Request in writing from Weil (copying the wind-down committee) and from the proposed receiving firm:
Matter list. Every open matter, with the responsible partner, the team members and each person’s destination firm.
Deadlines. All court, agency and contractual deadlines through March 31, 2027.
Data inventory. All client data held at Weil or by its vendors, with the planned transfer method and date.
Protective orders. Each order affected, with the notice and consent steps required.
Deal roles. All opinions, agent roles and notices naming Weil or a Weil lawyer.
Money. A final billing reconciliation covering billed, unbilled, retainers and AFAs.
Insurance. The tail coverage and the claims-notice contact.
Receiving firm conflicts. Written results, including any screens or waivers sought.
One name. A single transition coordinator at each firm, accountable to you.
THE BROADER LESSON: FIRM STABILITY IS A DILIGENCE ITEM
Weil did not collapse because of a malpractice verdict or a fraud. Its revenue grew less than 3% in 2025 while the largest firms grew more than 13%. It fell from ninth to twentieth in profits per partner over six years. In a market where the most sought-after partners can command more than $25 million a year, it lost the partners who held the client relationships. Stroock dissolved in 2023, and Dewey & LeBoeuf and Howrey ended in bankruptcy before that. The pattern is not new. The scale is.
For the legal department, that means three changes to how outside counsel is managed:
Hire the lawyer, document the firm. Most CLOs already know their relationship is with a person. Make the contract reflect it: outside counsel guidelines should require prompt notice of any departure of the responsible partner, any merger negotiation and any firm-level event affecting staffing.
Watch the signals. Partner departures in a practice group, failed merger talks, leadership succession problems and lagging financial performance are all public and are all reported. Someone on your team should be reading them for every firm handling a bet-the-company matter.
Do not put a company-defining matter in one firm without a plan B. For your largest litigation and most significant transactions, know which firm you would move to, whether it is conflicted, and how long the move would take. You will not need the plan often. When you do, you will need it within weeks.
THREE WORKSTREAMS
IMMEDIATE — If You Have Weil Matters
Send the letter in the box this week. Build a single tracker covering every Weil matter: destination firm, substitution status, protective-order steps, data transfer, deal roles, final billing and tail coverage. Set December 15 as your internal deadline, not December 31. The last two weeks of the year will be the worst time to find a missing step.
BUSINESS IMPACT: The transition will happen whether you manage it or not. If you do not manage it, the lateral market will decide where your matter goes, your docket will be reconstructed from memory, and opposing counsel will choose when to raise the protective order.
NEAR-TERM — Add a Firm-Event Clause to Your Outside Counsel Guidelines
Amend outside counsel guidelines and engagement letters to require written notice within five business days of:
the departure of a responsible partner;
merger or combination negotiations;
a dissolution or wind-down vote;
a material change in professional liability coverage.
Require a transition plan on request. Require the firm to cooperate with file and data transfer at no charge.
BUSINESS IMPACT: The clause costs nothing to add at renewal. It turns news you would otherwise learn from a trade publication into an obligation the firm owes you.
STRATEGIC — Map Your Panel Concentration
List your top ten matters by business impact and the firm handling each. For each, identify:
the backup firm;
whether it is conflicted;
how long a move would take.
Review the list annually alongside firm-health signals. Report it to the general counsel’s leadership team or the audit committee as part of legal risk reporting.
BUSINESS IMPACT: Concentration risk is a term every CFO understands. Applying it to outside counsel is the kind of operational discipline that changes how the C-suite views legal. It is the shift Issue #18 described.
“[The firm] will continue serving clients with the dedication and excellence that have defined it.”
— Weil, Gotshal & Manges statement, as reported by Bloomberg Law (Oct. 28, 2026)
Make sure that sentence is true for your matters by December 15.
Ive prepared a Law Firm Exit and Transition Toolkit. It can be found at https://laroccaadvisory.gumroad.com/l/ydsysd.
ABOUT THE AUTHOR
John LaRocca is a New York and New Jersey-barred attorney with 37 years of legal experience, including approximately 26 years as GC or CLO at specialty pharma and biotech companies including Actavis, Eagle Pharmaceuticals, Aerie Pharmaceuticals, and Y-mAbs Therapeutics. His transactions include the Aerie/Alcon acquisition (~$930M) and Y-mAbs/SERB acquisition ($412M, 105% premium). He runs LaRocca Advisory Services, a fractional CLO practice for PE-backed specialty pharma and commercial-stage biotech. Subscribe at laroccaj.substack.com.


